Skip to contentMathers Edward T — Bright Health Group Inc. insider: 149 transactions · InsiderLensMathers Edward T
- 10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
- 10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
- Director at Bright Health Group Inc. · on record since Oct 6, 2025
- 10% owner at SCHERING PLOUGH CORP · on record since Feb 11, 2026
- 10% owner at Bright Health Group Inc. · on record since Jun 24, 2021
- Director at Ra Pharmaceuticals, Inc. · on record since Oct 25, 2016
- Director at Trevi Therapeutics, Inc. · on record since Jun 4, 2026
- Director at MBX Biosciences, Inc. · on record since Jun 5, 2026
- Director at OnKure Therapeutics, Inc. · on record since Jun 8, 2026
- Director at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
- Director at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 4, 2017
- Director at Liquidia Corp · on record since Jul 27, 2018
- Director at Mirum Pharmaceuticals, Inc. · on record since Jul 17, 2019
- Director at Akouos, Inc. · on record since Jun 25, 2020
- Director at Inozyme Pharma, Inc. · on record since Jul 24, 2020
- 10% owner at ADVENTRX PHARMACEUTICALS INC · on record since Mar 16, 2021
- 10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
- Director at SENESCO TECHNOLOGIES INC · on record since Jun 15, 2022
- Director at ObsEva SA · on record since Jan 3, 2023
- SVP, Corporate Development at MEDIMMUNE INC /DE · on record since May 31, 2005
Insider trading activity of Mathers Edward T
- Transactions on record
- 149
- since Feb 7, 2006
- Open-market buys
- 6
- $47.3M
- Open-market sells
- 4
- $1.3M
- Companies traded
- 17
- last filing Jun 8, 2026
Figures computed from official regulatory filings — methodology.
Companies where Mathers Edward T has traded
- OnKure Therapeutics, Inc.10 tx · Jun 8, 2026
- MBX Biosciences, Inc.8 tx · $8M · Jun 5, 2026
- Trevi Therapeutics, Inc.10 tx · $7.5M · Jun 4, 2026
- RHYTHM PHARMACEUTICALS, INC.19 tx · Mar 16, 2026
- Korro Bio, Inc.3 tx · $6M · Mar 12, 2026
- SCHERING PLOUGH CORP9 tx · $15M · Feb 11, 2026
- Bright Health Group Inc.33 tx · $137.8M · Oct 6, 2025
- SENESCO TECHNOLOGIES INC5 tx · Jun 27, 2025
- Inozyme Pharma, Inc.5 tx · Jun 20, 2024
Track record of Mathers Edward T
Statistical track record
Free- Open-market buys
- 17
- Last buy
- Mar 10, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Mathers Edward T
Co-insiders of Mathers Edward T
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1 tx · $1M · Jul 19, 2023
Walker Paul EdwardADVENTRX PHARMACEUTICALS INC +8
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 8, 2026 | AwardD | 7,650 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | AwardD | 12,500 | 0.00 USD | $0 | SEC |
| Jun 4, 2026 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Mar 16, 2026 | Other | 4,199 | 0.00 USD | $0 | SEC |
| Mar 12, 2026 | Buy | 207,100 | 11.11 USD | $2.3M | SEC |
| Mar 12, 2026 | BuyD | 242,945 | 11.11 USD | $2.7M | SEC |
| Mar 4, 2026 | Other | 4,198 | 0.00 USD | $0 | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | Other | 737,962 | — | — | SEC |
| Feb 11, 2026 | Buy | 937,500 | 16.00 USD | $15M | SEC |
| Feb 11, 2026 | OtherD | -1,619,240 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | Other | 1,619,240 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -737,962 | — | — | SEC |
| Jan 2, 2026 | Award | 3,911 | 0.00 USD | $0 | SEC |
| Oct 6, 2025 | OtherD | -125,000 | — | — | SEC |
| Oct 6, 2025 | Sell | -2,455 | 6.75 USD | $16.6K | SEC |
| Oct 6, 2025 | OtherD | -100,000 | — | — | SEC |
| Oct 6, 2025 | Other | 607,536 | 0.01 USD | $6.1K | SEC |
| Oct 6, 2025 | Sell | -280 | 6.75 USD | $1.9K | SEC |
| Oct 6, 2025 | ExerciseD | -124,085 | 0.00 USD | $0 | SEC |
| Oct 6, 2025 | Sell | -900 | 6.75 USD | $6.1K | SEC |
| Oct 6, 2025 | Exercise | 124,085 | 0.01 USD | $1.2K | SEC |